Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Catheter PrecisionFRA:4RM 27 Cash Ratio is 0.02 as of Mar. 2026, which is 99% below its 10-year median of 2.77. GuruFocus rates FRA:4RM with a GF Score™ of 27/100 and a GF Value™ of €584.47. The stock has 7 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Catheter Precision ranks worse than 97.15% on this metric.
Catheter Precision has a Cash Ratio of 0.02. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Catheter Precision's Cash Ratio or its related term are showing as below:
FRA:4RM'
s Cash Ratio Range Over the Past 10 Years
Min: 0.02 Med: 2.77 Max: 10.84
Current: 0.02
During the past 10 years, Catheter Precision's highest Cash Ratio was 10.84. The lowest was 0.02. And the median was 2.77.
FRA:4RM's Cash Ratio is ranked worse than 97.15% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.98
vs FRA:4RM: 0.02
Catheter Precision (FRA:4RM) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Catheter Precision Cash Ratio Related Terms
Catheter Precision Cash Ratio Historical Data
* Premium members only.
The historical data trend for Catheter Precision's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4RM vs PFSA, BJDX, RBOT: Cash Ratio Comparison
For the Medical Devices subindustry, Catheter Precision's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Catheter Precision's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision (FRA:4RM) has a Cash Ratio of 0.02 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Catheter Precision and its competitors. This is 99% below median its historical median of 2.77. Over the past decade, Catheter Precision's Cash Ratio has ranged from 0.02 to 10.84. According to the industry distribution chart, Catheter Precision ranks #817 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 97.1%.
Is Catheter Precision's Cash Ratio too high?
Catheter Precision's current Cash Ratio of 0.02 is 99% below median its 10-year median of 2.77. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 10.84. The Medical Devices & Instruments industry median Cash Ratio is 0.98. Catheter Precision's value of 0.02 is 98% below this industry median. Based on the distribution chart, Catheter Precision ranks #817 out of 841 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Catheter Precision has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Cash Ratio compare to PFSA and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #817 out of 841 companies for Cash Ratio. This places Catheter Precision in the lower half of its industry. The industry median Cash Ratio is 0.98. Catheter Precision's value of 0.02 is 98% below this benchmark. Historically, Catheter Precision's own Cash Ratio has ranged from 0.02 to 10.84 over the past decade. While the company's 10-year median is 2.77 vs. the industry median of 0.98, Catheter Precision has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.98, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Catheter Precision's current Cash Ratio of 0.02 is 98% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Catheter Precision and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current Cash Ratio is 0.02, which is 99% below median its own 10-year median of 2.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Catheter Precision (FRA:4RM) has a current Cash Ratio of 0.02. The stock's GF Value™ is €584.47, compared to a current price of €100.89 — trading 82.7% below its estimated fair value. The current Cash Ratio is 0.02, which is 99% below median its 10-year median of 2.77 and 98% below the Medical Devices & Instruments industry median of 0.98. Catheter Precision's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current Cash Ratio is 0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (FRA:4RM) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of €100.89 is trading 82.7% below its estimated GF Value™ of €584.47.
Key valuation signals for FRA:4RM:
Cash Ratio: 0.02 (99% below median its 10-year median of 2.77)
GF Value™: €584.47 vs. price of €100.89 (82.7% below fair value)
Industry Position: 98% below the Medical Devices & Instruments median (#817 of 841)
No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
27GF Score
Get the complete analysis for FRA:4RM
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4RM has been successfully added to your 
